INS and diabetes mellitus: Inflammation affects insulin signalling [32] and increases beta-cell death [33], and markers of inflammation, such as elevated interleukin 6 (IL-6) and C-reactive protein (CRP) levels, have been found to be associated with future diabetes risk [34],[35].